Related Experiment Video
Updated: May 22, 2026

07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
PV-1 is recognized by the PAL-E antibody and forms complexes with NRP-1
Johannes Keuschnigg1, Denis Tvorogov, Kati Elima
1MediCity Research Laboratory, University of Turku, Turku, Finland.
Blood
|May 26, 2012
Summary
The Pathological Anatomy Leiden Endothelium (PAL-E) antibody targets plasmalemma vesicle-associated protein-1 (PV-1), not neuropilin-1 (NRP-1). However, PV-1 and NRP-1 form complexes, impacting leukocyte trafficking and angiogenesis.
Area of Science:
- Vascular biology
- Immunohistochemistry
- Molecular cell biology
Background:
- The Pathological Anatomy Leiden Endothelium (PAL-E) antibody is a long-standing marker for vascular endothelium.
- Its precise molecular target has been debated, with plasmalemma vesicle-associated protein-1 (PV-1) and neuropilin-1 (NRP-1) being proposed candidates.
Purpose of the Study:
- To definitively identify the molecular target of the PAL-E antibody.
- To investigate the relationship between PV-1 and NRP-1 in endothelial cells.
Main Methods:
- Immunofluorescence staining in various tissues.
- Flow cytometry analysis of transfected cells.
- Western blotting and co-immunoprecipitation assays using tissue and cell lysates.
Main Results:
- PAL-E and anti-PV-1 antibodies exhibited identical staining patterns to anti-CD31 and anti-NRP-1 antibodies in tissues.
- PV-1-transfected cells bound PAL-E and anti-PV-1, while NRP-1 transfectants bound anti-NRP-1.
- PAL-E and anti-PV-1 antibodies recognize PV-1, not NRP-1.
- NRP-1 and PV-1 were shown to form molecular complexes.
Conclusions:
- The PAL-E antibody specifically recognizes PV-1.
- NRP-1 and PV-1 interact, forming complexes relevant to leukocyte trafficking and angiogenesis.
- This interaction opens new avenues for research in endothelial cell biology and related pathologies.

